pointofcar
test
poct
laboratorymedicin
disciplin
evolv
rapidli
analyt
scope
clinic
applic
review
first
describ
state
art
medicallaboratori
test
perform
near
patient
present
poct
rang
basic
bloodglucos
measur
complex
viscoelast
coagul
assay
poct
shorten
time
clinic
decisionmak
addit
test
therapi
delay
longer
caus
transport
prepar
clinic
sampl
biochemicaltest
result
rapidli
avail
point
care
improv
medic
outcom
lower
cost
may
ensu
recent
evolv
technolog
advanc
enabl
develop
novel
poct
instrument
review
underli
analyt
techniqu
new
instrument
yet
practic
use
often
hard
decid
whether
underli
analyt
principl
real
advantag
former
method
howev
futur
util
poct
also
depend
healthcar
trend
new
area
applic
even
today
assum
certain
applic
nearpati
test
use
complement
convent
laboratori
analys
larg
number
laboratori
analys
support
correct
diagnosi
diseas
addit
aid
monitor
drug
therapi
mani
case
laboratori
medicin
therefor
vital
compon
differenti
diagnosi
clinic
local
gener
practic
afford
compet
system
laboratori
diagnost
offic
hospit
made
possibl
central
analysi
purposebuilt
laboratori
facil
provid
larg
hospit
contrast
central
increas
effici
laboratori
diagnost
recent
trend
toward
decentr
diagnost
analysi
socal
pointofcar
test
poct
occur
directli
bed
oper
theatr
outpati
clinic
site
accid
modern
varieti
laboratori
medicin
character
minim
instrument
size
procedur
increas
use
current
inform
technolog
analyt
devic
avail
make
possibl
process
whole
blood
sampl
simpl
manner
allow
untrain
staff
carri
laboratori
diagnost
clear
use
poct
shorten
time
sampl
acquisit
analysi
turnaround
time
howev
type
diagnosi
use
result
produc
lead
immedi
therapeut
decis
howev
still
pauciti
evid
support
use
poct
improv
patient
outcom
nevertheless
difficult
predict
growth
develop
poct
diagnost
paramet
present
avail
central
laboratori
growth
support
new
analyt
technolog
amalgam
issu
eg
miniatur
nanoparticl
techniqu
multiplex
wireless
connect
novel
biomark
clinic
patholog
disciplin
need
respons
field
sinc
adher
qualitymanag
system
ensur
accur
reliabl
biochemicaltest
result
optim
patient
care
safeti
regardless
whether
individu
test
perform
central
laboratori
poct
bedsid
poct
mainli
character
proxim
patient
quantit
semiquantit
singl
measur
short
turnaround
time
sampl
prepar
pipet
use
premad
reagent
userfriendli
dedic
analyt
instrument
instant
resultdeduc
therapeut
action
outpati
ward
personnel
expect
abl
use
analyz
previou
knowledg
sampl
analysi
requir
howev
continu
transit
poct
laboratorybas
method
gener
accept
definit
poct
still
debat
exampl
viscoelast
coagul
test
describ
articl
type
poct
perform
near
patient
case
activ
bleed
result
avail
quickli
allow
instant
therapeut
action
howev
caregiv
mostli
overstrain
oper
viscoelast
apparatu
often
analys
perform
central
laboratori
onlin
transmiss
sensorgram
oper
room
analyz
call
pseudopoct
current
annual
turnov
poct
vitro
diagnost
europ
stand
approxim
germani
contribut
major
come
bloodsugartest
strip
devic
home
test
diabet
past
year
market
poct
system
grew
yearli
rapid
growth
slightli
dampen
sinc
nevertheless
mark
increas
expect
midterm
longterm
tabl
give
insight
varieti
paramet
avail
present
current
techniqu
categor
stateoftheart
poct
devic
poct
devic
often
employ
biosensor
fig
accord
iupac
definit
biosensor
analyt
devic
detect
analyt
combin
biolog
compon
physicochemicaldetector
compon
gener
occur
use
miniatur
analysi
system
biolog
compon
immobil
solidst
surfac
turn
interact
analyt
interact
may
detect
use
either
electrochem
optic
method
latter
case
larg
role
play
fluoresc
reflect
spectroscopi
differ
paramet
characterist
certain
diseas
detect
use
specif
biomolecul
poct
analyz
current
avail
separ
variou
group
attempt
categor
instrument
accord
practic
use
poct
moreov
follow
attribut
sensor
characterist
complex
measur
mode
underli
detect
principl
andor
sampl
matrix
simplest
form
quantit
poct
devic
analysi
take
place
respect
test
strip
reader
use
read
result
strip
reaction
alreadi
taken
place
test
strip
oneus
articl
exampl
includ
figur
biosensor
basi
analysi
mani
pointofcar
test
poct
instrument
note
recognit
layer
may
compris
attach
recognit
element
antibodi
receptor
aptam
immobil
enzym
latter
case
addit
substrat
essenti
illustr
fact
amplifi
signal
final
process
microelectron
display
glucomet
home
hospit
poct
station
well
istat
abbott
abbott
park
il
usa
multiparamet
unitus
poct
instrument
bloodsugar
analysi
histor
financi
commonli
use
poct
techniqu
valid
inpati
outpati
care
home
test
patient
although
gener
either
capillari
venou
blood
use
result
present
bloodglucos
plasmaglucos
level
depend
calibr
manufactur
make
relev
differ
potenti
result
fals
therapeut
measur
minim
risk
confus
wholeblood
plasmaglucos
result
intern
feder
clinic
chemistri
laboratori
medicin
ifcc
suggest
glucos
valu
given
plasma
level
independ
sampl
type
measur
method
usa
countri
alreadi
follow
recommend
also
implement
germanspeak
region
strong
correl
intern
normal
ratio
inr
clinic
outcom
oral
anticoagul
vitamin
k
antagonist
warfarin
marcumar
led
tight
therapymonitor
regim
use
inr
poct
devic
inr
test
may
perform
offic
patient
home
test
popular
devic
see
tabl
system
use
unitus
test
strip
whole
blood
obtain
finger
prick
make
conveni
patient
differ
type
sensit
thromboplastin
use
differ
signal
type
micromechan
versu
electrochem
caus
systemat
differ
result
obtain
differ
inr
devic
howev
betweenday
precis
devic
seem
satisfactori
monitor
perform
one
singl
type
devic
instrument
gener
complex
unitus
machin
use
differ
analyt
principl
spectrophotometr
substrat
enzymeact
measur
hematolog
particl
count
immunoassay
sensorbas
bloodga
analysi
tailor
special
poct
applic
use
antibodybas
immunoassay
methodolog
bga
use
potentiometricamperometr
optic
sensor
ph
po
pco
addit
ionsensit
electrod
measur
electrolyt
substrat
avail
select
system
seven
marketdomin
manufactur
given
tabl
option
configur
bga
cooximetri
unit
remark
technic
develop
cooximetri
unit
miniatur
multiwavelength
spectrophotomet
measur
typic
absorpt
spectra
variou
hemoglobin
hb
speci
order
distinguish
hb
oxyhb
hb
speci
determin
hb
satur
ie
percentag
hb
compar
total
amount
hb
includ
cohb
hb
deoxygen
hb
hhb
fe
methb
hhb
fe
lead
compani
market
sophist
oximetri
unit
board
bloodga
analyz
counterpart
central
medic
laboratori
technolog
diversif
factor
hb
speci
found
insid
erythrocyt
henc
system
use
celllysi
step
prior
spectrophotometri
wherea
other
elimin
erythrocytecaus
light
scatter
appli
matrixassist
algorithm
poct
compat
machin
show
high
degre
complex
although
valid
use
poct
qualifi
personnel
oper
eg
laboratori
physician
train
technic
assist
combin
analysi
plasma
clot
thrombocyt
function
fibrinolysi
term
viscoelast
coagul
test
exampl
includ
rotem
tem
intern
munich
germani
sonoclot
sienco
inc
arvada
co
usa
also
possibl
analyz
platelet
function
term
vitro
bleed
time
via
optic
aggregometri
exampl
pfa
siemen
healthcar
diagnost
eschborn
germani
verifynow
accumetr
san
diego
ca
usa
describ
introduct
analyz
call
pseudopoct
common
exampl
continu
glucos
monitor
analyz
applic
system
alreadi
avail
commerci
like
replac
invas
intraven
electrod
minim
invas
locat
microdialysi
cathet
subcutan
tissu
fig
convers
noninvas
method
eg
micropor
optic
techniqu
direct
transcutan
measur
metabol
paramet
least
unlik
prevail
mainli
due
broad
rang
humanskin
characterist
concern
thick
pigment
hairi
well
physiolog
phenomena
eg
humid
salt
content
current
avail
system
continu
glucos
monitor
guardian
rt
medtron
minneapoli
mn
usa
glucoday
menarini
type
molecular
biologybas
poct
devic
detect
infecti
agent
present
market
mani
qualit
test
strip
detect
infecti
pathogen
basic
principl
system
immunochromatographi
specif
microbi
antigen
rare
antibodi
patient
sampl
urin
swab
whole
blood
also
attempt
use
molecular
biolog
method
mostli
polymeras
chain
reaction
qrt
pcr
poct
although
technic
demand
dnarnaextract
step
requir
rapid
test
strict
sens
yet
due
complex
test
procedur
challeng
interpret
result
futur
rapid
nucleicacid
test
nat
like
locat
central
laboratori
rather
bedsid
nevertheless
rapid
quantif
dnarna
variou
infecti
agent
benefici
clinic
diagnost
present
genexpert
system
cepheid
sunnyval
ca
usa
cuttingedg
devic
autom
integr
realtim
pcrbase
nat
step
sampl
prepar
dna
amplif
detect
system
randomaccess
instrument
integr
realtim
cycler
amplif
fluoresc
detect
use
multipl
fluoresc
dye
permit
multiplex
assay
detect
sever
target
within
singl
sampl
system
provid
pcrtest
result
raw
clinic
sampl
h
enabl
timecrit
nat
point
need
seri
differ
unitus
microfluid
cartridg
insert
analyz
eg
xpert
sa
nasal
complet
cartridg
design
detect
aureu
mrsa
colon
nasal
pharyng
swab
flu
apanel
cartridg
alreadi
evalu
current
avail
novel
poct
system
part
forerunn
new
gener
laboratori
system
domin
market
time
fourthgener
laboratori
system
method
character
miniatur
parallel
analys
network
via
inform
technolog
miniatur
microfluid
chip
technolog
electrochem
detect
enabl
construct
miniatur
system
even
dna
may
directli
analyz
microlit
sampl
immunoassay
method
protein
determin
may
also
carri
microtot
analysi
system
lta
advantag
miniatur
obviou
fluid
volum
nl
pl
rang
reduc
amount
reagent
requir
also
time
need
basic
analyt
process
eg
mix
equilibr
parallel
chip
technolog
open
possibl
measur
multipl
channel
multipl
time
point
smallest
space
photolithograph
techniqu
allow
reaction
reservoir
liquid
channel
etch
wafer
enabl
measur
taken
simultan
even
higher
densiti
reaction
alreadi
realiz
gene
analysi
use
microarray
appropri
microautom
system
allow
multipl
laboratori
profil
establish
rapidli
cost
effect
therebi
open
possibl
obtain
overview
situat
minut
use
pattern
laboratori
valu
contrast
singl
paramet
may
least
principl
open
new
diagnost
prognost
avenu
howev
attend
problem
evalu
interpret
massiv
amount
data
thu
obtain
remain
unsolv
network
nextgener
laboratori
system
gener
network
via
intern
commun
standard
alreadi
exist
purpos
howev
current
pointtopoint
commun
eg
decentr
bloodglucos
monitor
laboratori
system
show
modest
begin
futur
discuss
individu
electron
patient
file
laboratori
valu
variou
sourc
directli
input
link
result
present
wave
novel
analyt
principl
instrument
envis
near
futur
includ
altern
biolog
detect
element
scaffold
aptam
anticalin
place
antibodi
sophist
applic
opticalsign
technolog
total
intern
reflect
fluoresc
surfac
plasmon
reson
reflectometr
interfer
spectroscopi
new
dedic
microarray
inflamm
malign
autoantibodi
diagnost
process
encourag
innov
commun
industri
particularli
via
wireless
network
wifi
technolog
follow
detail
refer
new
instrument
market
shortli
analyz
cartridgebas
instrument
allow
determin
albumincreatinin
ratio
acr
crp
reflectometri
test
whole
blood
plasma
urin
sampl
use
advantag
devic
short
assay
time
allinon
reagent
cartridg
eas
applic
tech
handheld
immunoassay
machin
carri
immunolog
reaction
use
magnetiz
nanoparticl
particl
label
antibodi
expos
variabl
magnet
field
detect
perform
boundfromfre
separ
reaction
compon
current
use
frustrat
total
intern
reflect
method
nanoparticl
also
use
socal
giant
magnetoresist
effect
signal
gener
expect
instrument
provid
multianalyt
detect
mode
spectrum
paramet
eg
cardiac
marker
parathormon
sepsi
paramet
compani
develop
new
signalgener
detect
technolog
poct
instrument
use
piezo
film
made
polyvinyl
fluorid
act
pyroelectr
film
therebi
enabl
ultrasensit
nonsepar
assay
design
immunoassay
eg
cardiac
marker
thyroid
hormon
led
light
strike
piezo
film
caus
thermal
disturb
subsequ
chang
charg
signal
howev
case
carbon
particlelabel
immuno
complex
previous
bound
label
antibodi
free
solut
bound
surfac
caus
chang
charg
piezo
film
analyz
innov
technolog
base
establish
detect
principl
realiz
new
multipl
analyz
dynabyt
munich
germani
devic
use
imped
aggregometri
principl
assess
platelet
function
whole
blood
blood
thrombocyt
nonthrombogen
rest
state
expos
receptor
surfac
activ
allow
attach
vascular
injuri
artifici
surfac
eg
sensor
wire
platelet
aggreg
multipl
wire
enhanc
electr
resist
continu
record
order
enhanc
resist
sensor
wire
tight
attach
platelet
requir
number
plateletstimul
test
reagent
avail
specif
comprehens
platelet
diagnost
type
continu
measur
poct
system
continu
mode
poct
measur
minimallyinvas
microdialysi
system
becom
accept
best
approach
nevertheless
desir
clinic
access
probe
intraven
line
long
time
unfulfil
clinic
desir
recent
microey
system
probe
scientif
ltd
coventri
uk
enabl
continu
autom
monitor
substanc
circul
blood
stream
without
withdraw
blood
patient
appli
intraven
microdialysi
cathet
http
wwwprobescientificcommicroey
mani
compani
current
work
differ
poctsuit
dnaamplif
techniqu
eg
quantit
detect
influenza
panel
enteroviru
strain
nanospher
northbrook
il
usa
verigen
system
use
goldnanoparticleprob
technolog
detect
infecti
dna
rna
probe
technolog
use
chang
optic
properti
gold
nanoparticl
occur
two
nanoparticl
brought
close
proxim
wavelength
light
scatter
surfac
particl
within
visibl
rang
easili
detect
detail
distancedepend
optic
properti
gold
nanoparticl
portray
fig
enigma
salisburi
wiltshir
uk
compani
work
provid
next
gener
integr
autom
realtim
pcrbase
diagnost
system
dxna
st
georg
ut
usa
mobil
poct
technolog
genestat
provid
rtpcrbase
detect
sever
acut
respiratori
syndrom
sar
highli
pathogen
avian
influenza
idaho
technolog
salt
lake
citi
ut
usa
filmarray
system
userfriendli
autom
multiplex
pcr
iquum
marlborough
usa
liat
analyz
offer
innov
labinatub
platform
detect
genotyp
dnarna
virus
bacteria
number
novel
paramet
poct
applic
discuss
potenti
interest
still
clinic
unevalu
new
marker
poct
applic
follow
ngal
neutrophil
gelatinaseassoci
lipocalin
ngal
test
acut
renal
failur
bgalactosidebind
protein
test
fibrosi
advers
cardiac
remodel
copeptin
ctermin
residu
proavp
earli
diagnosi
myocardi
infarct
combin
placent
growth
factor
pigf
solubl
fmslike
tyrosin
kinas
endoglin
earli
diagnosi
preeclampsia
mani
possibl
extend
applic
poct
depend
wish
need
practic
aris
use
poct
well
advantag
disadvantag
patient
mani
peopl
involv
discuss
clinic
laboratori
medic
personnel
doctor
practic
polit
regulatori
author
state
privat
health
insur
industri
least
patient
furthermor
applic
poct
must
scientif
ground
evid
base
eg
via
outcom
analysi
partli
case
date
financi
viabl
financi
viabil
strongli
associ
respect
nation
reimburs
system
variou
test
countri
mainli
question
healthcar
polit
qualiti
poct
assur
poctcoordin
system
clinic
laboratori
play
pivot
role
poct
activ
discuss
agre
upon
clinic
clinic
laboratori
mani
exampl
fruit
cooper
even
today
howev
futur
necess
structur
search
protocol
new
poct
method
agreement
core
laboratori
method
clinic
colleagu
assum
clinic
accept
result
variat
caus
poct
method
new
rule
need
assess
agreement
certain
analyt
result
two
differ
methodolog
analyt
case
eg
step
b
dna
probe
hybrid
dna
target
solut
spot
onto
glass
slide
step
c
hybrid
gold
nanoparticl
scatter
h
plasmon
efffect
induc
red
light
shift
scheme
present
accord
bloodglucos
prothrombintim
monitor
errorgrid
analysi
use
determin
cutoff
differ
central
laboratori
poct
result
may
impact
clinic
decis
novel
statist
approach
yet
defin
data
manag
poct
result
also
fundament
qualiti
tight
surveil
poct
data
show
error
trend
affect
result
howev
prerequisit
comprehens
connect
poct
system
use
within
hospitalwid
network
newer
poct
devic
datastorag
function
collect
key
inform
time
test
perform
later
transmit
result
togeth
intern
qualitycontrol
data
serverbas
poct
data
manag
softwar
link
inform
system
hospit
recent
develop
connect
standard
eg
enabl
differ
poct
devic
share
common
interfac
poct
datamanag
softwar
program
categor
proprietari
nonproprietari
exampl
first
categori
coba
roch
radianc
radiomet
rapidcomm
siemen
healthcar
nonproprietari
softwar
solut
eu
poceler
conworx
berlin
germani
usa
quicklinc
telcor
lincoln
ne
usa
wireless
realtim
commun
test
result
qualiti
data
becom
realiti
near
futur
number
patient
requir
inpati
treatment
hospit
togeth
length
stay
like
declin
near
futur
advantag
outpati
treatment
patient
observ
home
environ
import
poct
increas
area
outpati
care
clear
advantag
immedi
diagnost
therapeut
decis
offer
patient
may
need
investig
enlarg
current
paramet
spectrum
also
import
doctor
practic
addit
test
avail
mean
identifi
infecti
agent
would
requir
homecar
extend
apart
glucos
inr
monitor
new
test
chronic
diseas
becom
readili
avail
import
trend
context
term
person
medicin
case
chronic
diseas
eg
diabet
atherosclerosi
would
diagnos
earlier
tradit
clinic
diagnosi
focus
clinic
sign
symptom
therapeut
strategi
would
tailor
patient
individu
thu
improv
result
treatment
fig
telemedicin
increasingli
import
area
instrument
use
monitor
patient
right
circumst
send
data
obtain
directli
relev
medic
servic
point
interven
eg
critic
valu
exceed
effect
home
monitor
thu
patient
safeti
improv
though
poct
may
use
principl
local
use
today
mainli
center
variou
area
hospit
gener
practition
patient
selfmonitor
glucos
inr
beyond
potenti
use
discuss
inde
albeit
mostli
small
number
alreadi
realiz
includ
mobil
emerg
paramed
care
blood
mobil
mobil
public
event
transport
vehicl
eg
ambul
helicopt
sport
medicin
competit
sport
outbreak
diseas
catastroph
remot
area
third
world
countri
militari
use
pharmaci
prison
alternativemedicin
practition
corpor
healthcar
oper
nurs
home
veterinari
medicin
fit
studio
home
healthcar
mani
case
equip
current
avail
well
spectrum
paramet
partli
suitabl
futur
develop
rais
accept
level
therefor
use
poct
specif
area
avail
medic
treatment
popul
whole
particularli
import
develop
countri
current
western
system
eg
structur
around
larg
central
hospit
larg
unsuit
rather
decentr
health
system
offer
effect
mean
case
decentr
diagnost
process
poct
system
play
use
part
success
movement
direct
eg
reserv
australian
aborigin
howev
widespread
use
current
avail
system
hinder
cost
complex
unreli
extrem
condit
heat
humid
paramet
offer
often
meet
requir
situat
american
nation
institut
biomed
imag
bioengin
nibib
therefor
begun
cooper
india
aim
develop
devic
suitabl
use
point
need
intern
council
standard
hematolog
icsh
work
set
guidelin
applic
worldwid
poct
standard
hematolog
also
use
develop
countri
special
novel
rapid
microbiolog
test
must
develop
recogn
common
infect
agent
countri
bill
melinda
gate
foundat
sponsor
research
direct
order
establish
simpl
poct
applic
aid
patient
socal
initi
make
possibl
count
posit
tlymphocyt
hivinfect
patient
view
better
control
antiretrovir
therapi
valu
poct
epidem
diseas
develop
countri
demonstr
follow
exampl
tuberculosi
treatment
hamper
slow
insensit
diagnost
method
particularli
detect
drugresist
form
earli
diagnosi
essenti
reduc
mortal
interrupt
transmiss
insuffici
healthcar
infrastructur
poor
countri
limit
access
effect
boehm
et
al
assess
perform
autom
molecular
identif
mycobacterium
tuberculosi
mtb
test
resist
rifampin
rif
genexpert
mtbrif
system
mention
appli
sputum
sampl
patient
peru
azerbaijan
south
africa
india
result
author
state
mtbrif
test
provid
sensit
detect
tuberculosi
rifampin
resist
directli
untreat
sputum
less
h
test
specif
patient
without
tuberculosi
compar
phenotyp
drugsuscept
test
mtbrif
test
correctli
identifi
patient
rifampinresist
bacteria
rifampinsensit
bacteria
devic
definit
applic
rural
area
without
compromis
lack
analyt
qualiti
futur
project
take
account
poct
principl
brought
simpli
patient
necessarili
expertis
laboratori
doctor
difficult
imagin
complex
panel
analys
eg
tumor
marker
genet
suscept
test
suppli
via
poct
could
interpret
without
adequ
technic
expertis
knowledg
therefor
vital
interest
patient
poct
employ
laboratori
medic
personnel
suggest
appropri
test
carri
satisfactorili
specif
problem
involv
problem
qualiti
assess
wide
use
poct
area
outsid
standard
hospit
environ
gener
practition
lead
new
problem
qualiti
assur
clear
today
use
poct
without
relev
train
personnel
lead
unsatisfactori
result
endus
reli
compet
laboratori
medic
advisori
servic
least
difficulti
aris
develop
relev
equip
like
result
inbuilt
qualiti
control
current
procedur
intern
extern
control
becom
obsolet
howev
problem
end
use
untrain
unsupervis
personnel
increas
particularli
respect
preanalysi
patient
prepar
sampl
acquisit
recognit
invalid
sampl
postanalysi
document
data
protect
notabl
case
poct
use
area
far
laboratori
eg
develop
countri
import
task
laboratori
medicin
whole
make
clear
poct
analysi
meet
medic
requir
rest
reliabl
analysi
system
